|
|
Activated O2 •-and H2O2mediated cell survival in SU11274-treated non-small-cell lung cancer A549 cells via c-Met-PI3K-Akt and c-Met-Grb2/SOS-Ras-p38 pathways
|
|
|
|
|
نویسنده
|
liu y. ,shi q.-f. ,ye y.-c. ,tashiro s.-i. ,onodera s. ,ikejima t.
|
منبع
|
journal of pharmacological sciences - 2012 - دوره : 119 - شماره : 2 - صفحه:150 -159
|
چکیده
|
The pharmacological activity of su11274 is primarily due to its inhibition of hepotocyte growth factor receptor (c-met) kinase overexpression. in this study,we demonstrated that the pathway involved in su11274-induced autophagy was presumably through inhibition of c-met and its down-stream pathways,including phosphatidylinositol 3-kinases - akt (pi3k-akt) and the growth factor receptor bound protein-2 / son of sevenless - ras - p38 mapk (grb2/sos-ras-p38) pathway. su11274 time-dependently induced the generation of superoxide anion (o2 •-) and hydrogen peroxide (h2o2). there is a negative feedback loop between reactive oxygen species (ros) induction and su11274. then,we investigated the role of ros in protecting cells against su11274-induced autophagic cell death in a549 cells. o2 •-and h2o2generation activated c-met-pi3k-akt and c-met-grb2/sos-ras-p38 signaling pathways,which were suppressed by o2 •-scavenger superoxide dismutase (sod) and h2o2scavenger catalase. in conclusion,o2 •-and h2o2evoked cell resistance to su11274 via activating c-met-pi3k-akt and c-met-grb2/sos-ras-p38 pathways in a549 cells. su11274 also induced ros generation in caenorhabditis elegans. © the japanese pharmacological society.
|
کلیدواژه
|
A549 cell; c-Met; Hydrogen peroxide; SU11274; Superoxide anion
|
آدرس
|
china-japan research institute of medical and pharmaceutical sciences,shenyang pharmaceutical university,103 wenhua road,shenyang,liaoning 110016, China, china-japan research institute of medical and pharmaceutical sciences,shenyang pharmaceutical university,103 wenhua road,shenyang,liaoning 110016, China, china-japan research institute of medical and pharmaceutical sciences,shenyang pharmaceutical university,103 wenhua road,shenyang,liaoning 110016, China, department of clinical and biomedical science,showa pharmaceutical university,tokyo 194-8543, Japan, department of clinical and biomedical science,showa pharmaceutical university,tokyo 194-8543, Japan, china-japan research institute of medical and pharmaceutical sciences,shenyang pharmaceutical university,103 wenhua road,shenyang,liaoning 110016, China
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|